The RSI Indicator for CURE moved into overbought territory on November 21, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CURE broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on November 10, 2025. You may want to consider a long position or call options on CURE as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CURE just turned positive on November 11, 2025. Looking at past instances where CURE's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
The 50-day moving average for CURE moved above the 200-day moving average on November 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 267 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Category Trading
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ANFVX | 15.03 | 0.42 | +2.87% |
| Virtus NFJ Small-Cap Value R6 | |||
| EIVIX | 15.01 | 0.24 | +1.62% |
| Allspring Special Large Cap Value Inst | |||
| NGREX | 10.22 | 0.12 | +1.19% |
| Northern Global Real Estate Index | |||
| STPAX | 23.05 | 0.09 | +0.39% |
| Saratoga Technology & Comm A | |||
| JFAMX | 38.65 | -0.12 | -0.31% |
| JPMorgan Emerging Markets Equity A | |||
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with SPXL. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then SPXL could also see price increases.
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +6.37% | ||
| SPXL - CURE | 55% Loosely correlated | +2.93% | ||
| SSO - CURE | 55% Loosely correlated | +1.97% | ||
| QULL - CURE | 50% Loosely correlated | N/A | ||
| QLD - CURE | 41% Loosely correlated | +1.47% | ||
| TQQQ - CURE | 41% Loosely correlated | +2.22% | ||
More | ||||